These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7680946)

  • 1. High-risk germ cell tumors in men. High response rate and severe toxicity with cisplatin, vinblastine, bleomycin, and etoposide.
    Blayney DW; Goldberg DA; Leong LA; Margolin KA; Burke JS; Doroshow JH
    Cancer; 1993 Apr; 71(7):2351-7. PubMed ID: 7680946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.
    Ozols RF; Ihde DC; Linehan WM; Jacob J; Ostchega Y; Young RC
    J Clin Oncol; 1988 Jun; 6(6):1031-40. PubMed ID: 2453619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
    Culine S; Théodore C; Bekradda M; Farhat F; Terrier-Lacombe MJ; Droz JP
    Am J Clin Oncol; 1997 Apr; 20(2):184-8. PubMed ID: 9124197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
    Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
    J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide.
    Williams SD; Birch R; Einhorn LH; Irwin L; Greco FA; Loehrer PJ
    N Engl J Med; 1987 Jun; 316(23):1435-40. PubMed ID: 2437455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of poor prognosis germ cell tumours with high dose cisplatin regimens.
    Ozols RF
    Int J Androl; 1987 Feb; 10(1):291-300. PubMed ID: 2438222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential trials of cisplatin, vinblastine, and bleomycin and etoposide and cisplatin in disseminated nonseminomatous germ cell tumors of the testis with a good prognosis at a single institution.
    Germá JR; Sagarra AF; Izquierdo MA; Seguí MA
    Cancer; 1993 Feb; 71(3):796-803. PubMed ID: 7679314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.
    Culine S; Kattan J; Lhomme C; Duvillard P; Michel G; Castaigne D; Leclere J; Pico J; Droz JP
    Gynecol Oncol; 1994 Jul; 54(1):47-53. PubMed ID: 7517380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
    Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
    J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II trial of VP-16, ifosfamide, cisplatin, vinblastine, and bleomycin in advanced germ-cell tumors.
    Blanke C; Loehrer PJ; Nichols CR; Einhorn LH
    Am J Clin Oncol; 1996 Oct; 19(5):487-91. PubMed ID: 8823477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
    Broun ER; Nichols CR; Turns M; Williams SD; Loehrer PJ; Roth BJ; Lazarus HM; Einhorn LH
    Cancer; 1994 Mar; 73(6):1716-20. PubMed ID: 7512438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of poor prognosis nonseminomatous testicular cancer with a "high-dose" platinum combination chemotherapy regimen.
    Ozols RF; Deisseroth AB; Javadpour N; Barlock A; Messerschmidt GL; Young RC
    Cancer; 1983 May; 51(10):1803-7. PubMed ID: 6187426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival after vinblastine, bleomycin, and cisplatin treatment in patients with germ cell tumors of the ovary: an update.
    Willemse PH; Aalders JG; Bouma J; Mulder NH; Verschueren RC; de Vries EG; Sleijfer DT
    Gynecol Oncol; 1987 Nov; 28(3):268-77. PubMed ID: 2445635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of bleomycin pulmonary toxicity on the outcomes of patients with germ cell tumors.
    Maruyama Y; Sadahira T; Mitsui Y; Araki M; Wada K; Tanimoto R; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
    Med Oncol; 2018 Apr; 35(6):80. PubMed ID: 29700638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours.
    Pedersen-Bjergaard J; Daugaard G; Hansen SW; Philip P; Larsen SO; Rørth M
    Lancet; 1991 Aug; 338(8763):359-63. PubMed ID: 1713639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
    Peckham MJ; Barrett A; Liew KH; Horwich A; Robinson B; Dobbs HJ; McElwain TJ; Hendry WF
    Br J Cancer; 1983 May; 47(5):613-9. PubMed ID: 6189504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with vinblastine, bleomycin, cisplatin, and etoposide (VBPE) in children with primary intracranial germ cell tumors.
    Chang TK; Wong TT; Hwang B
    Med Pediatr Oncol; 1995 Jun; 24(6):368-72. PubMed ID: 7536294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma.
    Peckham MJ; Horwich A; Blackmore C; Hendry WF
    Cancer Treat Rep; 1985 May; 69(5):483-8. PubMed ID: 2408750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian germ cell malignancies: the Yale University experience.
    Schwartz PE; Chambers SK; Chambers JT; Kohorn E; McIntosh S
    Gynecol Oncol; 1992 Apr; 45(1):26-31. PubMed ID: 1376294
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy of refractory germ cell cancer with Etoposide.
    Lederman GS; Garnick MB; Canellos GP; Richie JP
    J Clin Oncol; 1983 Nov; 1(11):706-9. PubMed ID: 6321675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.